- Home
- SGMO vs FGBI Comparison
SGMO vs FGBI Comparison
Compare SGMO & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- FGBI
- Stock Information
- Founded
- SGMO 1995
- FGBI 1934
- Country
- SGMO United States
- FGBI United States
- Employees
- SGMO N/A
- FGBI N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- FGBI Savings Institutions
- Sector
- SGMO Health Care
- FGBI Finance
- Exchange
- SGMO Nasdaq
- FGBI Nasdaq
- Market Cap
- SGMO 122.8M
- FGBI 122.8M
- IPO Year
- SGMO 2000
- FGBI N/A
- Fundamental
- Price
- SGMO $0.68
- FGBI $8.82
- Analyst Decision
- SGMO Strong Buy
- FGBI
- Analyst Count
- SGMO 7
- FGBI 0
- Target Price
- SGMO $5.29
- FGBI N/A
- AVG Volume (30 Days)
- SGMO 5.4M
- FGBI 7.6K
- Earning Date
- SGMO 11-11-2025
- FGBI 10-30-2025
- Dividend Yield
- SGMO N/A
- FGBI 0.45%
- EPS Growth
- SGMO N/A
- FGBI N/A
- EPS
- SGMO N/A
- FGBI N/A
- Revenue
- SGMO $81,706,000.00
- FGBI $59,070,000.00
- Revenue This Year
- SGMO $28.47
- FGBI N/A
- Revenue Next Year
- SGMO N/A
- FGBI $0.20
- P/E Ratio
- SGMO N/A
- FGBI N/A
- Revenue Growth
- SGMO 565.52
- FGBI N/A
- 52 Week Low
- SGMO $0.41
- FGBI $6.56
- 52 Week High
- SGMO $3.18
- FGBI $15.25
- Technical
- Relative Strength Index (RSI)
- SGMO 66.82
- FGBI 65.44
- Support Level
- SGMO $0.65
- FGBI $7.85
- Resistance Level
- SGMO $0.73
- FGBI $8.25
- Average True Range (ATR)
- SGMO 0.06
- FGBI 0.15
- MACD
- SGMO 0.02
- FGBI 0.02
- Stochastic Oscillator
- SGMO 67.74
- FGBI 95.11
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.